Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $0.8 in the prior trading day, SeaStar Medical Holding Corp (NASDAQ: ICU) closed at $0.83, up 3.20%. In other words, the price has increased by $3.20 from its previous closing price. On the day, 0.9 million shares were traded. ICU stock price reached its highest trading level at $0.85 during the session, while it also had its lowest trading level at $0.812.
Ratios:
Our goal is to gain a better understanding of ICU by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.52. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 30 ’25 when Baird Jennifer A bought 10,000 shares for $0.42 per share. The transaction valued at 4,174 led to the insider holds 28,000 shares of the business.
Neuman John bought 40,000 shares of ICU for $14,396 on Jun 24 ’25. The Director now owns 80,000 shares after completing the transaction at $0.36 per share. On May 20 ’25, another insider, Baird Jennifer A, who serves as the Director of the company, bought 10,000 shares for $1.28 each. As a result, the insider paid 12,815 and bolstered with 10,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ICU now has a Market Capitalization of 23107678 and an Enterprise Value of 16855948. For the stock, the TTM Price-to-Sale (P/S) ratio is 30.07 while its Price-to-Book (P/B) ratio in mrq is 4.31. Its current Enterprise Value per Revenue stands at 22.005.
Stock Price History:
The Beta on a monthly basis for ICU is -0.99, which has changed by -0.8628099 over the last 52 weeks, in comparison to a change of 0.15222645 over the same period for the S&P500. Over the past 52 weeks, ICU has reached a high of $6.90, while it has fallen to a 52-week low of $0.31. The 50-Day Moving Average of the stock is 12.08%, while the 200-Day Moving Average is calculated to be -46.59%.
Shares Statistics:
The stock has traded on average 7.59M shares per day over the past 3-months and 1625020 shares per day over the last 10 days, according to various share statistics. A total of 27.91M shares are outstanding, with a floating share count of 26.61M. Insiders hold about 4.66% of the company’s shares, while institutions hold 1.73% stake in the company. Shares short for ICU as of 1753920000 were 2071239 with a Short Ratio of 0.27, compared to 1751241600 on 2945797. Therefore, it implies a Short% of Shares Outstanding of 2071239 and a Short% of Float of 9.22.
Earnings Estimates
At present, 1.0 analysts are actively evaluating the performance of SeaStar Medical Holding Corp (ICU) in the stock market.The consensus estimate for the next quarter is -$0.17, with high estimates of -$0.17 and low estimates of -$0.17.
Analysts are recommending an EPS of between -$0.77 and -$0.77 for the fiscal current year, implying an average EPS of -$0.77. EPS for the following year is -$0.46, with 1.0 analysts recommending between -$0.46 and -$0.46.
Revenue Estimates
1 analysts predict $300k in revenue for the current quarter. It ranges from a high estimate of $300k to a low estimate of $300k. As of the current estimate, SeaStar Medical Holding Corp’s year-ago sales were $68kFor the next quarter, 1 analysts are estimating revenue of $400k. There is a high estimate of $400k for the next quarter, whereas the lowest estimate is $400k.
A total of 1 analysts have provided revenue estimates for ICU’s current fiscal year. The highest revenue estimate was $1.33M, while the lowest revenue estimate was $1.33M, resulting in an average revenue estimate of $1.33M. In the same quarter a year ago, actual revenue was $135kBased on 1 analysts’ estimates, the company’s revenue will be $2.28M in the next fiscal year. The high estimate is $2.28M and the low estimate is $2.28M.
